{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:55:49Z","timestamp":1794030949767,"version":"4.8.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Adenomyosis is a benign gynecological condition in which endometrial tissue or endometrial-like tissue develops within the uterine myometrium. Few cases of disseminated intravascular coagulation has been reported in the patients with adenomyosis. Although hysterectomy is indicated for refractory massive uterine bleeding in the patients with advanced uterine adenomyosis, conservative treatment is often desired in women in the late reproductive age. Recently such cases are increasing due to the social trend of late marriage.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 37-year-old woman with huge adenomyosis, gravida 2 para 0, was referred to our hospital to terminate her pregnancy. Acute, non-septic, disseminated intravascular coagulation (DIC) developed after early pregnancy was terminated in a woman with huge adenomyosis. Massive bleeding and DIC occurred 3 days after the dilatation and curettage. There was no evidence of infection as the cause of the DIC, because neither bacteria nor endotoxin could be detected in her blood, and antithrombin 3 (AT3), which would be expected to decrease in septic patients, was not decreased. Hemorrhage in the adenomyotic tissue after the termination presumably developed inflammation, with numerous microthrombi and necrosis in the adenomyotic tissue, which subsequently promoted coagulation and fibrinolysis, leading to the onset of massive uterine bleeding and DIC. Although severe hyperfibrinolysis is observed in peripheral blood, the fibrinolysis state in the uterine myometrium is considered to be even more severe. The newly formed clots for hemostasis under the uterine mucosa could be removed due to the excessive activation of fibrinolytic system happened in the adjacent myometrium, leading to the onset of massive uterine bleeding. Massive bleeding and DIC resolved quickly after the patient was treated with nafamostat mesilate, which is effective for both excessive coagulation and fibrinolysis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Adenomyosis could cause massive bleeding and DIC when pregnancy is terminated. Massive bleeding was considered to occur because the excessive fibrinolysis system inside adenomyosis affected the adjacent endometrium. Before considering hysterectomy to control refractory uterine bleeding, nafamostat mesilate should be considered as one option, thinking the pathophysiology of the massive bleeding due to uterine adenomyosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12905-020-00924-8","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T12:04:25Z","timestamp":1584619465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Successful conservative treatment for massive uterine bleeding with non-septic disseminated intravascular coagulation after termination of early pregnancy in a woman with huge adenomyosis: case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Fuminori","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimasa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kitazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukuru","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"key":"924_CR1","first-page":"96","volume":"29","author":"DI Feinstein","year":"2015","unstructured":"Feinstein DI. Disseminated intravascular coagulation in patients with solid tumors. Oncology. 2015;29:96\u2013102.","journal-title":"Oncology"},{"issue":"Suppl 1","key":"924_CR2","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1016\/S0049-3848(16)30101-3","volume":"140","author":"M Levi","year":"2016","unstructured":"Levi M. Management of cancer-associated disseminated intravascular coagulation. Thromb Res. 2016;140(Suppl 1):S66\u201370.","journal-title":"Thromb Res"},{"key":"924_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1055\/s-0030-1254048","volume":"36","author":"M Franchini","year":"2010","unstructured":"Franchini M, Di Minno MN, Coppola A. Disseminated intravascular coagulation in hematologic malignancies. Semin Thromb Hemost. 2010;36:388\u2013403.","journal-title":"Semin Thromb Hemost"},{"key":"924_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/AOG.0000000000001110","volume":"126","author":"FG Cunningham","year":"2015","unstructured":"Cunningham FG, Nelson DB. Disseminated intravascular coagulation syndromes in obstetrics. Obstet Gynecol. 2015;126:999\u20131011. https:\/\/doi.org\/10.1097\/AOG.0000000000001110.","journal-title":"Obstet Gynecol"},{"key":"924_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ajog.2015.03.054","volume":"213","author":"O Erez","year":"2015","unstructured":"Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol. 2015;213:452\u201363. https:\/\/doi.org\/10.1016\/j.ajog.2015.03.054.","journal-title":"Am J Obstet Gynecol"},{"key":"924_CR6","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/j.1651-2227.2001.tb03243.x","volume":"90","author":"J Antovic","year":"2001","unstructured":"Antovic J, Bakic M, Milicevic R, Gojkovic G, Blomb\u00e4ck M. Activation of the coagulation system occurs within rather than outside cutaneous haemangiomas. Acta Paediatr. 2001;90:1137\u201340.","journal-title":"Acta Paediatr"},{"key":"924_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s004040100243","volume":"267","author":"Y Nakamura","year":"2002","unstructured":"Nakamura Y, Kawamura N, Ishiko O, Ogita S. Acute disseminated intravascular coagulation developed during menstruation in an adenomyosis patient. Arch Gynecol Obstet. 2002;267:110\u20132.","journal-title":"Arch Gynecol Obstet"},{"key":"924_CR8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/MBC.0b013e3283641917","volume":"24","author":"J Zhang","year":"2013","unstructured":"Zhang J, Xiao X, Luo F, Shi G, He Y, Yao Y, Xu L. Acute disseminated intravascular coagulation developed after dilation and curettage in an adenomyosis patient: a case report. Blood Coagul Fibrinolysis. 2013;24:771\u20133. https:\/\/doi.org\/10.1097\/MBC.0b013e3283641917.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"924_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.fertnstert.2017.12.030","volume":"109","author":"J Garc\u00eda-Solares","year":"2018","unstructured":"Garc\u00eda-Solares J, Donnez J, Donnez O, Dolmans MM. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril. 2018;109:371\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.12.030.","journal-title":"Fertil Steril"},{"key":"924_CR10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/09513590.2016.1197200","volume":"32","author":"A Pontis","year":"2016","unstructured":"Pontis A, D\u2019Alterio MN, Pirarba S, de Angelis C, Tinelli R, Angioni S. Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol. 2016;32:696\u2013700.","journal-title":"Gynecol Endocrinol"},{"key":"924_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jmig.2015.09.018","volume":"23","author":"J Struble","year":"2016","unstructured":"Struble J, Reid S, Bedaiwy MA. Adenomyosis: a clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol. 2016;23:164\u201385. https:\/\/doi.org\/10.1016\/j.jmig.2015.09.018.","journal-title":"J Minim Invasive Gynecol"},{"key":"924_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/humupd\/dmg010","volume":"9","author":"R Devlieger","year":"2003","unstructured":"Devlieger R, D'Hooghe T, Timmerman D. Uterine adenomyosis in the infertility clinic. Hum Reprod Update. 2003;9:139\u201347.","journal-title":"Hum Reprod Update"},{"key":"924_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5482\/HAMO-13-07-0039","volume":"33","author":"KA Krychtiuk","year":"2013","unstructured":"Krychtiuk KA, Kastl SP, Speidl WS, Wojta J. Inflammation and coagulation in atherosclerosis. Hamostaseologie. 2013;33:269\u201382.","journal-title":"Hamostaseologie"},{"key":"924_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/ACO.0000000000000163","volume":"28","author":"J Simmons","year":"2015","unstructured":"Simmons J, Pittet JF. The coagulopathy of acute sepsis. Curr Opin Anaesthesiol. 2015;28:227\u201336.","journal-title":"Curr Opin Anaesthesiol"},{"key":"924_CR15","doi-asserted-by":"publisher","first-page":"e107881","DOI":"10.1371\/journal.pone.0107881","volume":"9","author":"O Reiker\u00e5s","year":"2014","unstructured":"Reiker\u00e5s O, Borgen P. Activation of markers of inflammation, coagulation and fibrinolysis in musculoskeletal trauma. PLoS One. 2014;9:e107881.","journal-title":"PLoS One"},{"key":"924_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejogrb.2016.07.499","volume":"204","author":"A Yamanaka","year":"2016","unstructured":"Yamanaka A, Kimura F, Yoshida T, Kita N, Takahashi K, Kushima R, et al. Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia. Eur J Obstet Gynecol Reprod Biol. 2016;204:99\u2013103. https:\/\/doi.org\/10.1016\/j.ejogrb.2016.07.499.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"924_CR17","doi-asserted-by":"publisher","first-page":"910.e1","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.10.017","volume":"21","author":"K Yamashiro","year":"2012","unstructured":"Yamashiro K, Tanaka R, Nishioka K, Ueno Y, Shimura H, Okuma Y, et al. Cerebral infarcts associated with adenomyosis among middle-aged women. J Stroke Cerebrovasc Dis. 2012;21:910.e1\u20135. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2011.10.017.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"924_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5653\/cerm.2014.41.4.174","volume":"41","author":"JY Lee","year":"2014","unstructured":"Lee JY, Hwang KR, Won KH, Lee DY, Jeon HW, Moon MH. Uterine infarction in a patient with uterine adenomyosis following biochemical pregnancy. Clin Exp Reprod Med. 2014;41:174\u20137. https:\/\/doi.org\/10.5653\/cerm.2014.41.4.174.","journal-title":"Clin Exp Reprod Med"},{"key":"924_CR19","first-page":"498","volume":"178","author":"M Shimada","year":"1994","unstructured":"Shimada M, Matsumata T, Shirabe K, Kamakura T, Taketomi A, Sugimachi K. Effect of nafamostat mesilate on coagulation and fibrinolysis in hepatic resection. J Am Coll Surg. 1994;178:498\u2013502.","journal-title":"J Am Coll Surg"},{"key":"924_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1055\/s-0038-1650224","volume":"75","author":"S Sundaram","year":"1996","unstructured":"Sundaram S, Gikakis N, Hack CE, Niewiarowski S, Edmunds LH Jr, Koneti Rao A, et al. Nafamostat mesilate, a broad spectrum protease inhibitor, modulates platelet, neutrophil and contact activation in simulated extracorporeal circulation. Thromb Haemost. 1996;75:76\u201382.","journal-title":"Thromb Haemost"},{"key":"924_CR21","doi-asserted-by":"publisher","first-page":"e2392","DOI":"10.1097\/MD.0000000000002392","volume":"94","author":"JY Choi","year":"2015","unstructured":"Choi JY, Kang YJ, Jang HM, Jung HY, Cho JH, Park SH, et al. Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial. Medicine (Baltimore). 2015;94:e2392.","journal-title":"Medicine (Baltimore)"},{"key":"924_CR22","first-page":"978743","volume":"2014","author":"A Taneichi","year":"2014","unstructured":"Taneichi A, Fujiwara H, Mizoguchi Y, Machida S, Nonaka H, Takei Y, et al. Disseminated intravascular coagulopathy caused by uterine leiomyoma with sarcoma-like findings on magnetic resonance imaging. Case Rep Obstet Gynecol. 2014;2014:978743.","journal-title":"Case Rep Obstet Gynecol"},{"key":"924_CR23","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/0741-5214(87)90278-3","volume":"6","author":"H Mukaiyama","year":"1987","unstructured":"Mukaiyama H, Shionoya S, Ikezawa T, Kamiya T, Hamaguchi M, Saito H. Abdominal aortic aneurysm complicated with chronic disseminated intravascular coagulopathy: a case of surgical treatment. J Vasc Surg. 1987;6:600\u20134.","journal-title":"J Vasc Surg"},{"key":"924_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2052-0492-2-20","volume":"2","author":"H Asakura","year":"2014","unstructured":"Asakura H. Classifying types of disseminated intravascular coagulation: clinical and animal models. J Intensive Care. 2014;2:20.","journal-title":"J Intensive Care"},{"key":"924_CR25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/0005-2744(81)90023-1","volume":"661","author":"S Fujii","year":"1981","unstructured":"Fujii S, Hitomi Y. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin. Biochim Biophys Acta. 1981;661:342\u20135.","journal-title":"Biochim Biophys Acta"},{"key":"924_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1254\/jjp.35.203","volume":"35","author":"T Aoyama","year":"1984","unstructured":"Aoyama T, Ino Y, Ozeki M, Oda M, Sato T, Koshiyama Y, et al. Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments. Jpn J Pharmacol. 1984;35:203\u201327.","journal-title":"Jpn J Pharmacol"},{"key":"924_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1292\/jvms.09-0369","volume":"72","author":"T Shimokawa Miyama","year":"2010","unstructured":"Shimokawa Miyama T, Yoshioka C, Minami K, Okawa T, Hiraoka H, Itamoto K, et al. Nafamostat mesilate is not appropriate as an anticoagulant during continuous renal replacement therapy in dogs. J Vet Med Sci. 2010;72:363\u20137.","journal-title":"J Vet Med Sci"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-00924-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12905-020-00924-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-00924-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:19:48Z","timestamp":1616113188000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-020-00924-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1186\/s12905-020-00924-8","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,19]]},"assertion":[{"value":"4 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our institute allows us to report a case report in journals if the patient agrees to it.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained informed written consent to report the clinical information from the patient. Informed written consent was obtained for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}